Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Epidemiology of psoriasis in hard-to-treat body locations: data from the Danish skin cohort

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Employment is maintained and sick days decreased in psoriasis/psoriatic arthritis patients with etanercept treatment

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. miR-125b induces cellular senescence in malignant melanoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Chronic hand eczema - self-management and prognosis: a study protocol for a randomised clinical trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Association between head and neck cancer and sexually transmitted diseases: a Danish nationwide, case-control study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Drug survival of guselkumab for psoriasis in a real-world setting: a single-center retrospective chart review

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Prevalence, Incidence, and Risk of Cancer in Patients With Psoriasis and Psoriatic Arthritis: A Systematic Review and Meta-analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. How does parental history of atopic disease predict the risk of atopic dermatitis in a child? A systematic review and meta-analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Having psoriasis in hard-to-treat areas, i.e. the scalp, face, palms, soles, nails, and genitals, respectively, can impair patients' quality of life. We investigated the prevalence of hard-to-treat body locations of psoriasis, and described patients' clinical and demographic characteristics, and quality of life impacts in a population-based cohort.

METHODS: We performed a cross-sectional study using a total of 4016 adults (≥18 years) with psoriasis from the Danish Skin Cohort. Groups were compared to patients without involvement of hard-to-treat areas.

RESULTS: The most frequently affected hard-to-treat area was the scalp (43.0%), followed by the face (29.9%), nails (24.5%), soles (15.6%), genitals (14.1%), and palms (13.7%), respectively. Higher prevalence was generally seen with increasing psoriasis severity. Among all patients 64.8, 42.4, and 21.9% of patients had involvement of ≥1, ≥2, or ≥ 3 hard-to-treat areas. Those with involvement of certain hard-to-treat areas such as hands, feet, and genitals had clinically relevant DLQI impairments. Having involvement of one hard-to-treat area was significantly associated with other hard-to-treat areas affected even after adjusting for age, sex, and psoriasis severity.

CONCLUSION: Psoriasis commonly affects hard-to-treat locations, even in patients with mild disease. For some of these areas, patient-reported disease burden, e.g. as measured by DLQI, is impaired.

Original languageEnglish
JournalBMC Dermatology
Volume20
Issue number1
Pages (from-to)3
ISSN1471-5945
DOIs
Publication statusPublished - 20 May 2020

ID: 60481547